Metformin augments doxorubicin cytotoxicity in mammary carcinoma through activation of adenosine monophosphate protein kinase pathway.
about
Metformin augments doxorubicin cytotoxicity in mammary carcinoma through activation of adenosine monophosphate protein kinase pathway.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Metformin augments doxorubicin ...... sphate protein kinase pathway.
@en
Metformin augments doxorubicin ...... sphate protein kinase pathway.
@nl
type
label
Metformin augments doxorubicin ...... sphate protein kinase pathway.
@en
Metformin augments doxorubicin ...... sphate protein kinase pathway.
@nl
prefLabel
Metformin augments doxorubicin ...... sphate protein kinase pathway.
@en
Metformin augments doxorubicin ...... sphate protein kinase pathway.
@nl
P2093
P2860
P356
P1433
P1476
Metformin augments doxorubicin ...... sphate protein kinase pathway.
@en
P2093
Hend E Abo Mansour
Hoda A El-Bahrawy
Nahla E El-Ashmawy
P2860
P304
1010428317692235
P356
10.1177/1010428317692235
P577
2017-05-01T00:00:00Z